Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Raskob, Gary
One or more keywords matched the following items that are connected to
Raskob, Gary
Item Type
Name
Concept
Risk
Concept
Risk Factors
Concept
Risk Assessment
Academic Article
Hemorrhagic complications of anticoagulant treatment.
Academic Article
Chemical (VX) terrorist threat: public knowledge, attitudes, and responses.
Academic Article
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
Academic Article
The design and implementation of a new surveillance system for venous thromboembolism using combined active and passive methods.
Academic Article
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
Academic Article
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
Academic Article
Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
Academic Article
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials.
Academic Article
Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
Academic Article
Hemorrhagic complications of anticoagulant treatment.
Academic Article
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
Academic Article
Hemorrhagic complications of long-term anticoagulant therapy.
Academic Article
A new noninvasive management strategy for patients with suspected pulmonary embolism.
Academic Article
Effect of treatment with low-dose warfarin-aspirin on activated factor VII.
Academic Article
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.
Academic Article
Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.
Academic Article
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
Academic Article
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
Academic Article
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials.
Academic Article
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
Academic Article
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
Academic Article
Global public awareness of venous thromboembolism.
Academic Article
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
Academic Article
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
Academic Article
Global public awareness of venous thromboembolism: reply.
Academic Article
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.
Academic Article
New paradigms in venous thromboprophylaxis of medically ill patients.
Academic Article
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
Academic Article
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
Academic Article
Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma.
Academic Article
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
Academic Article
Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management.
Academic Article
Aging and heparin-related bleeding.
Academic Article
Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
Academic Article
Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Academic Article
Prevention of central venous catheter-associated thrombosis: a meta-analysis.
Academic Article
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
Academic Article
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
Academic Article
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Academic Article
Epidemiology and pathogenesis of venous thrombosis.
Academic Article
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
Academic Article
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
Academic Article
Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis.
Academic Article
Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting.
Academic Article
Hemorrhagic complications of anticoagulant treatment.
Academic Article
Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests.
Academic Article
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.
Academic Article
Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop.
Academic Article
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
Academic Article
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.
Academic Article
Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial.
Academic Article
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
Academic Article
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
Academic Article
The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.
Academic Article
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.
Academic Article
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.
Academic Article
Prophylaxis of venous thromboembolism. An overview.
Academic Article
Risk of haemorrhage associated with long term anticoagulant therapy.
Academic Article
Hemorrhagic complications of anticoagulant treatment.
Academic Article
Long-term oral anticoagulant therapy for coronary artery disease.
Academic Article
Duration of anticoagulant treatment for venous thrombosis.
Grant
THROMBOSIS: ETIOLOGY, RISK FACTORS AND TREATMENT
Grant
OU Developmental Center for Injury Prevention Research
Academic Article
Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER.
Academic Article
Abelacimab for Prevention of Venous Thromboembolism. Reply.
Academic Article
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
Academic Article
Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis.
Academic Article
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.
Academic Article
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
Academic Article
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
Academic Article
Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population.
Academic Article
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.
Academic Article
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
Search Criteria
Risk